From professional translators, enterprises, web pages and freely available translation repositories.
the efficacy results from the hera trial are summarized in the following table:
efektyvumo rezultatai hera tyrimo duomenimis susumuoti toliau pateiktoje lentelje:
early breast cancer in the hera trial was limited to operable, primary, invasive adenocarcinoma of the breast, with axillary nodes positive or axillary nodes negative if tumours at least 1 cm in diameter.
hera tyrimo metu ankstyvasis krties vzys tai operuojama pirmin, invazin krties adenokarcinoma, kai pazastini limfmazgi tyrimo rezultatai teigiami arba neigiami ir jei navikai ne mazesnio nei 1 cm diametro.